NCT05488873 2024-07-22
A Study of Topical Pirenzepine or Placebo in Oncology Patients With Chemotherapy Induced Peripheral Neuropathy
WinSanTor, Inc
Phase 2 Active not recruiting
WinSanTor, Inc
Bristol-Myers Squibb
Aclaris Therapeutics, Inc.
GlaxoSmithKline